ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000225914.1	ABT-263 (navitoclax)	Colon adenocarcinoma	0.005205238	Resistant
ENSG00000225914.1	ABT-263 (navitoclax)	Lymphoid neoplasm diffuse large B-cell lymphoma	0.046290795	Sensitive